In many inflammatory dermatoses leukocyte function-associated antigen-
1/intercellular adhesion molecule-1 mediated T-cell/keratinocyte adhes
ion is considered to play an important role. Pentoxifylline (PTX), a m
ethylxanthine derivative widely used for the symptomatic treatment of
various vascular disorders, was recently found to have anti-inflammato
ry effects. PTX can suppress tumor necrosis factor-alpha production an
d function, and inhibits leukocyte-endothelial cell adherence. The aim
of the present study was to investigate whether PTX also interferes w
ith T-cell/keratinocyte binding. Peripheral blood T cells were activat
ed with phorbol myristate acetate and co-incubated with interferon-gam
ma- or tumor necrosis factor-alpha-stimulated keratinocytes (SVK 14 ce
lls) in the presence or absence of PTX. Using an enzyme-linked immune
cell adhesion assay PTX was found to inhibit T-cell/keratinocyte adhes
ion in a dose-dependent manner. A similar inhibition was found when PT
X was replaced by isobutylmethylxanthine, another methylxanthine deriv
ative, or by a combination of two cyclic adenosine monophosphate analo
gues. No major effect on T-cell/keratinocyte adherence was observed wh
en PTX was present during the pre-incubation of keratinocyte monolayer
s with tumor necrosis factor-alpha or interferon-gamma prior to the ad
hesion assay. In keratinocyte monolayers the interferon-gamma or tumor
necrosis factor-alpha induced intercellular adhesion molecule-1 expre
ssion could not be inhibited by PTX. However, when PTX was added to sh
ort-term organ cultures of normal human skin biopsies, the lipopolysac
charide- and tumor necrosis factor-alpha-induced keratinocyte intercel
lular adhesion molecule-1 expression was blocked completely. The inter
feron-gamma-induced ICAM-1 expression was not blocked by PTX. The resu
lts presented herein suggest that impaired T-cell/keratinocyte binding
may be one of the mechanisms by which PTX exerts a beneficial effect
in certain inflammatory dermatoses.